Discuva is a Cambridge (UK)-based Next Generation antibiotic discovery company with an experienced Pharma/Biotech management team and exceptional scientific pedigree. The company was established to address major gaps that exist in the current treatment of infective disease with antibiotics. Using proprietary methods which have come out of recent advances in genomic technologies, Discuva is developing targeted antibiotics against new emerging and drug-resistant pathogens.